The FDA's Risk Communication Advisory Committee will discuss the risk communication strategic plan and solicit input and advice.
The two-day public meeting will take place at the FDA's Center for Drug Evaluation and Research in the Advisory Committee Conference Room (Rm. 1066). The center is located at 5630 Fishers Lane, Rockville, MD.